Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Interest Expenses (2016 - 2025)

Altimmune (ALT) has disclosed Interest Expenses for 16 consecutive years, with $495000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Expenses rose 8150.0% to $495000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $761000.0, a 7510.0% increase, with the full-year FY2024 number at $9000.0, down 74.29% from a year prior.
  • Interest Expenses was $495000.0 for Q3 2025 at Altimmune, up from $264000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $495000.0 in Q3 2025 to a low of -$183000.0 in Q4 2022.
  • A 5-year average of $43024.4 and a median of $6000.0 in 2024 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: crashed 3262.47% in 2021, then skyrocketed 26300.0% in 2025.
  • Altimmune's Interest Expenses stood at -$61763.0 in 2021, then tumbled by 196.29% to -$183000.0 in 2022, then surged by 101.09% to $2000.0 in 2023, then plummeted by 50.0% to $1000.0 in 2024, then skyrocketed by 49400.0% to $495000.0 in 2025.
  • Per Business Quant, the three most recent readings for ALT's Interest Expenses are $495000.0 (Q3 2025), $264000.0 (Q2 2025), and $1000.0 (Q1 2025).